Inactive

See the attached MS Word document for more information: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) S... See the attached MS Word document for more information: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued. The solicitation number for this requirement is 75D30122-Q-74551 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 13.1 Simplified Acquisition Procedures. The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract for the following requirement, please either fill in the dollar amounts or provide a separate excel spreadsheet containing the same information including a list of line item number(s) and items, quantities, units of measure, and options, if applicable: CLIN 0001: QTY Unit Price Total Price Aptima HIV-1 Quant, US IVD, 100-Test 20 Kits $________ $________ Product # - PRD-03565 Your quote shall include the following: Unit Price for each Unit Total Price for CLIN 0001 Delivery Date: ASAP Delivery Instructions and Address: These are temperature sensitive laboratory items. To avoid contamination and spoilage, ship all items on this order directly from the manufacturer, Hologic/Gen-Probe, Inc, to: Silvina Masciotra Centers for Disease Control and Prevention 1600 Clifton Road, NE Mailstop H17-3, Bldg. 17, Room 3050 Atlanta, GA 30329 404-639-1004 ALL ITEMS ON THIS ORDER MUST BE SHIPPED IN ONE SHIPMENT, AND WITH THE LATEST EXPIRATION DATES (A MINIMUM OF (10 MONTHS FROM SHIPPING DATE). Acceptance and FOB point The quote format is at the discretion of the offeror. It is the offeror's responsibility to be familiar with the applicable clauses and provisions. Clauses and provisions may be accessed via the Internet at website http://farsite.hill.af.mil. This solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular (FAC) 2022-05 (effective March 7, 2022) This acquisition is set aside for small business concerns under North American Industry Classification System (NAICS) code 325413, In-Vitro Diagnostic Substance Manufacturing, and small business size standard 1250 employees. A Firm-Fixed Price purchase order will be issued in writing to the successful offeror. To be eligible to receive an award resulting from this solicitation, contractor must be registered in the System for Award Management. To register apply via the Internet at http://www.sam.gov. For questions on registration contact Federal Service Desk at 866-606-8220. Include FAR 52.212-3, Offeror Representations and Certifications with Offer or indicate if it is available online at SAM.gov. No telephonic quotes will be processed. All responses must be received no later than 2:00 P.M., Eastern Standard Time on May 11, 2022. Please send any questions and quotes to Liubov Kriel at vyh1@cdc.gov.

Inactive

The Center for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Laboratory Branch (LB), intends ... The Center for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Laboratory Branch (LB), intends to award a sole source purchase order to Gen-Probe Incorporated (“Hologic”), 250 Campus Dr, Marlborough, MA 01752 for the purchase of Aptima HIV-1 Quant DX kits. The statutory authority for this sole source acquisition is 41 U.S.C.1708 in accordance with FAR Part FAR 13.106-1(b)(1), only one source is reasonably available to satisfy the agency requirement. The NAICS code for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing. The purpose of this acquisition is to purchase HIV-1 Quant DX kits. This kit is the only FDA-approved assay available in the US that can be used for diagnosis and monitoring of HIV-1 infections. This kit is exclusively for use on the Hologic Panther platform that CDC has in the CLIA laboratory for patient reporting. The Division of HIV Prevention HIV Laboratory tests patient samples for HIV infection, which can only be done with reagent kits approved by the FDA and with the compatible instrument. Gen-Probe Incorporated is the only responsible source capable of meeting the Government’s requirement because they are the only vendor that can manufacture these kits. Kits from other manufacturers are not compatible and are not approved for use so cannot be considered. Thus, Gen-Probe Incorporated, the manufacturer of these kits, is the only company that can be used. As a result of this synopsis, no competitive solicitation will be posted on sam.gov. We will issue only one solicitation to Gen-Probe Incorporated. However, firms that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by March 25, 2022. The Contracting Officer will not respond to verbal request. All requests must be in writing. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall be sent to Liubov Kriel by email at vyh1@cdc.gov and reference solicitation number 75D301-22-Q-74551 on the subject line.